Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Healio celebrates 2023 Disruptive Innovators at ACG Katrina Altersitz
-
- What you missed at the 2023 Healio Disruptive Innovators awards Robert Stott
- Reimbursement system ‘broken’: Long-term solution needed for administrative burden Louis J. Wilson, MD, FACG
- AGA: Early diagnosis, treatment ‘essential’ in exocrine pancreatic insufficiency Kate Burba
- Cloud-based AI system enhances detection of adenomas, ‘difficult-to-detect’ polyps Monica Stonehill
- ‘Do not give up too early’: Early nonresponders with IBS-C improve on Ibsrela at 12 weeks Robert Stott
- FDA approves subcutaneous Entyvio as maintenance therapy for ulcerative colitis
- FDA updates Ozempic label to include warning for intestinal blockage, hypoglycemia risk
- FDA warns of ‘potentially fatal’ probiotic risk for preterm infants after patient dies
-
- Liver disease causes 50% of all deaths in first 5 years after alcohol-related diagnosis Kate Burba
- Mirikizumab rebounds to win FDA approval as first IL-23p19 agonist for ulcerative colitis
- New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Kate Burba
- Norovirus likely culprit of 2022 gastroenteritis outbreak among Pacific Crest Trail hikers Kate Burba
- Pegozafermin improves fibrosis in patients with NASH, could advance to phase 3 development Kate Burba
- Tea consumption may not be linked to development of colorectal cancer; more research needed Kate Burba
- VIDEO: AI tool helps identify pediatric patients with celiac disease, suboptimal follow-up Imad Absah, MD; Kate Burba
- VIDEO: Recognize IBD mimickers, but avoid ‘casting too large of a net’ Riha G. Bhatt, MD; Monica Stonehill
-